Detecting undiagnosed diabetes using glycated haemoglobin: An automated screening test in hospitalised patients

Medical Journal of Australia

Volumn 194, Issue 4, 2011, Pages 160-164

  Valentine, Nyoli A ^a,b   Alhawassi, Tariq M ^c   Roberts, Greg W ^d   Vora, Parid P ^e   Stranks, Stephen N ^e   Doogue, Matthew P ^b,e  

^a Sturt Fleurieu General Practice Education and Training   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d REPATRIATION GENERAL HOSPITAL   (Australia)

^e Southern Adelaide Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE;

EID: 79952461570     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2011.tb03762.x     Document Type: Article

References (23)

1. Barr E, Magliano D, Zimmet P, et al. AusDiab 2005. The Australian Diabetes, Obesity and Lifestyle Study. Tracking the accelerating epidemic: its causes and outcomes. Report. Melbourne: International Diabetes Institute, 2006.
2. Roper NA, Bilous RW, Kelly WF, et al. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ 2001; 322: 1389-1393. (Pubitemid 32523292)
3. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007; 24: 333-343. (Pubitemid 46452406)
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
5. Ealovega MW, Tabaei BP, Brandle M, et al. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 2004; 27: 9-12. (Pubitemid 38196701)
6. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009; 32 Suppl 1: S13-S61.
7. Screening for type 2 diabetes. Report of a World Health Organization and International Diabetes Federation meeting. Geneva: World Health Organization, 2003.
8. 1c among patients admitted to the hospital without a diagnosis of diabetes. J Clin Endocrinol Metab 2008; 93: 4238-4244.
9. 1c as risk factors for type 2 diabetes. Diabet Med 2008; 25: 1157-1163.
10. 1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care 2003; 26: 1064-1068.
11. World Health Organization. Diabetes mellitus, a report of the WHO Expert Committee. WHO Technical Report Series No. 310. Geneva: WHO, 1965.
12. 1c assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
13. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
14. Sabanayagam C, Liew G, Tai ES, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 2009; 52: 1279-1289.
15. Tapp RJ, Tikellis G, Wong TY, et al. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008; 31: 1349-1354.
16. Saudek CD, Herman WH, Sacks DB, et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008; 93: 2447-2453. (Pubitemid 352008502)
17. Australian Government, Department of Health and Ageing. Medical Benefits Schedule. DoHA, 2009.
18. Colagiuri S, Zimmet P, Hepburn A, Colagiuri R. Evidence based guidelines for type 2 diabetes: primary prevention, case detection and diagnosis. Canberra: Diabetes Australia and National Health and Medical Research Council, 2002.
19. Krebs JD, Robinson GM, Smith RB, et al. Follow up testing of hyperglycaemia during hospital admission: combined use of fasting plasma glucose and HbA1c. N Z Med J 2000; 113: 379-381.
20. Baker ST, Chiang CY, Zajac JD, et al. Outcomes for general medical inpatients with diabetes mellitus and new hyperglycaemia. Med J Aust 2008; 188: 340-343.
21. George PM, Valabhji J, Dawood M, et al. Screening for Type 2 diabetes in the accident and emergency department. Diabet Med 2005; 22: 1766-1769. (Pubitemid 43046483)
22. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834. (Pubitemid 41094278)
23. Garancini MP, Calori G, Ruotolo G, et al. Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study. Diabetologia 1995; 38: 306-313.